315 related articles for article (PubMed ID: 28855269)
21. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
22. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Hormonal Response to a Mixed-Meal Challenge in Hypoglycemia After Sleeve Gastrectomy vs Gastric Bypass.
Lee CJ; Clark JM; Egan JM; Carlson OD; Schweitzer M; Langan S; Brown T
J Clin Endocrinol Metab; 2022 Sep; 107(10):e4159-e4166. PubMed ID: 35914520
[TBL] [Abstract][Full Text] [Related]
24. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
Umeda LM; Silva EA; Carneiro G; Arasaki CH; Geloneze B; Zanella MT
Obes Surg; 2011 Jul; 21(7):896-901. PubMed ID: 21559794
[TBL] [Abstract][Full Text] [Related]
25. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery.
McLaughlin T; Peck M; Holst J; Deacon C
J Clin Endocrinol Metab; 2010 Apr; 95(4):1851-5. PubMed ID: 20133462
[TBL] [Abstract][Full Text] [Related]
26. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study.
Behary P; Tharakan G; Alexiadou K; Johnson N; Wewer Albrechtsen NJ; Kenkre J; Cuenco J; Hope D; Anyiam O; Choudhury S; Alessimii H; Poddar A; Minnion J; Doyle C; Frost G; Le Roux C; Purkayastha S; Moorthy K; Dhillo W; Holst JJ; Ahmed AR; Prevost AT; Bloom SR; Tan TM
Diabetes Care; 2019 Aug; 42(8):1446-1453. PubMed ID: 31177183
[TBL] [Abstract][Full Text] [Related]
27. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
[TBL] [Abstract][Full Text] [Related]
28. Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.
Khoo CM; Muehlbauer MJ; Stevens RD; Pamuklar Z; Chen J; Newgard CB; Torquati A
Ann Surg; 2014 Apr; 259(4):687-93. PubMed ID: 23787216
[TBL] [Abstract][Full Text] [Related]
29. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
Goldfine AB; Mun EC; Devine E; Bernier R; Baz-Hecht M; Jones DB; Schneider BE; Holst JJ; Patti ME
J Clin Endocrinol Metab; 2007 Dec; 92(12):4678-85. PubMed ID: 17895322
[TBL] [Abstract][Full Text] [Related]
30. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
[TBL] [Abstract][Full Text] [Related]
31. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
32. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
33. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
[TBL] [Abstract][Full Text] [Related]
34. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
Øhrstrøm CC; Worm D; Højager A; Andersen D; Holst JJ; Kielgast UL; Hansen DL
Diabetes Obes Metab; 2019 Sep; 21(9):2142-2151. PubMed ID: 31144430
[TBL] [Abstract][Full Text] [Related]
35. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
36. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
[TBL] [Abstract][Full Text] [Related]
37. Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery.
Jorsal T; Wewer Albrechtsen NJ; Christensen MM; Mortensen B; Wandall E; Langholz E; Friis S; Worm D; Ørskov C; Støving RK; Andries A; Juhl CB; Sørensen F; Forman JL; Falkenhahn M; Musholt PB; Theis S; Larsen PJ; Holst JJ; Vrang N; Jelsing J; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2019 Dec; 104(12):6403-6416. PubMed ID: 31276156
[TBL] [Abstract][Full Text] [Related]
38. The effects of postprandial exercise and meal glycemic index on plasma glucose and glucoregulatory hormone responses after Roux-en-Y gastric bypass.
Ternhamar T; Møller A; Martinussen C; Svane MS; Hindsø M; Jørgensen NB; Dirksen C; Jensen JB; Hartmann B; Holst JJ; Kiens B; Madsbad S; Bojsen-Møller KN
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E540-E551. PubMed ID: 37755455
[TBL] [Abstract][Full Text] [Related]
39. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
[TBL] [Abstract][Full Text] [Related]
40. More symptoms but similar blood glucose curve after oral carbohydrate provocation in patients with a history of hypoglycemia-like symptoms compared to asymptomatic patients after Roux-en-Y gastric bypass.
Laurenius A; Werling M; Le Roux CW; Fändriks L; Olbers T
Surg Obes Relat Dis; 2014; 10(6):1047-54. PubMed ID: 25205571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
